Peer review reports
From: Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen
| Original Submission |
| 30 Jun 2016 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
| Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
| Publishing |
| 11 Aug 2016 |
Editorially accepted |
|
| 18 Aug 2016 |
Article published |
10.1186/s12885-016-2711-5
|
Learn about peer review
